Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967325 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cyclin E1 (CCNE1) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Purified from tissue culture supernatant or ascites by affinity chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- HE12
- Vial size
- 150 μg
- Concentration
- 1.0 mg/ml
- Storage
- -20°C
Submitted references Cytometry of cyclin proteins.
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2.
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage.
Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase.
Transfer of behavioral function as a contributing factor in treatment relapse.
Cyclin E, a potential prognostic marker for breast cancer.
Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements.
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.
Mammalian G1 cyclins.
Expression of cyclins-B and cyclins-e in individual molt-4 cells and in stimulated human-lymphocytes during their progression through the cell-cycle.
Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F
Cytometry 1996 Sep 1;25(1):1-13
Cytometry 1996 Sep 1;25(1):1-13
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2.
Gorospe M, Liu Y, Xu Q, Chrest FJ, Holbrook NJ
Molecular and cellular biology 1996 Mar;16(3):762-70
Molecular and cellular biology 1996 Mar;16(3):762-70
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage.
Scuderi R, Palucka KA, Pokrovskaja K, Björkholm M, Wiman KG, Pisa P
Blood 1996 Apr 15;87(8):3360-7
Blood 1996 Apr 15;87(8):3360-7
Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Gong J, Bhatia U, Traganos F, Darzynkiewicz Z
Leukemia 1995 May;9(5):893-9
Leukemia 1995 May;9(5):893-9
Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase.
Gong J, Traganos F, Darzynkiewicz Z
Cell proliferation 1995 Jun;28(6):337-46
Cell proliferation 1995 Jun;28(6):337-46
Transfer of behavioral function as a contributing factor in treatment relapse.
Lerman DC, Iwata BA, Smith RG, Zarcone JR, Vollmer TR
Journal of applied behavior analysis 1994 Summer;27(2):357-70
Journal of applied behavior analysis 1994 Summer;27(2):357-70
Cyclin E, a potential prognostic marker for breast cancer.
Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB
Cancer research 1994 Jan 15;54(2):380-5
Cancer research 1994 Jan 15;54(2):380-5
Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements.
Gong J, Traganos F, Darzynkiewicz Z
Cancer research 1993 Nov 1;53(21):5096-9
Cancer research 1993 Nov 1;53(21):5096-9
The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.
Faha B, Harlow E, Lees E
Journal of virology 1993 May;67(5):2456-65
Journal of virology 1993 May;67(5):2456-65
Mammalian G1 cyclins.
Sherr CJ
Cell 1993 Jun 18;73(6):1059-65
Cell 1993 Jun 18;73(6):1059-65
Expression of cyclins-B and cyclins-e in individual molt-4 cells and in stimulated human-lymphocytes during their progression through the cell-cycle.
Gong J, Traganos F, Darzynkiewicz Z
International journal of oncology 1993 Dec;3(6):1037-42
International journal of oncology 1993 Dec;3(6):1037-42
No comments: Submit comment
No validations: Submit validation data